Literature DB >> 20394813

Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles.

Nan Zhang1, Jiahui Li, Wenfeng Jiang, Chunhong Ren, Jianshu Li, Jianyu Xin, Ke Li.   

Abstract

In an alginate/chitosan nanoparticle system, insulin was protected by forming complexes with cationic beta-cyclodextrin polymers (CPbetaCDs), which were synthesized from beta-cyclodextrin (beta-CD), epichlorohydrin (EP) and choline chloride (CC) through a one-step polycondensation. Due to the electrostatic attraction between insulin and CPbetaCDs, as well as the assistance of its polymeric chains, CPbetaCDs could effectively protect insulin under simulated gastrointestinal conditions. The nanoparticles have their mean size lower than 350 nm and can load insulin with the association efficiency (AE) up to 87%. It is notable that the cumulative insulin release in simulated intestinal fluid was significantly higher (40%) than that without CPbetaCDs (18%) because insulin was mainly retained in the core of the nanoparticles and well protected against degradation in simulated gastric fluid. Far-UV circular dichroism analysis also corroborated the preservation of insulin structure during the nanoparticle preparation and release process. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20394813     DOI: 10.1016/j.ijpharm.2010.04.006

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  23 in total

Review 1.  Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.

Authors:  Anumita Chaudhury; Surajit Das
Journal:  AAPS PharmSciTech       Date:  2010-12-11       Impact factor: 3.246

2.  Insulin-loaded pH-sensitive hyaluronic acid nanoparticles enhance transcellular delivery.

Authors:  Lina Han; Yuefang Zhao; Lifang Yin; Ruiming Li; Yang Liang; Huan Huang; Shirong Pan; Chuanbin Wu; Min Feng
Journal:  AAPS PharmSciTech       Date:  2012-05-30       Impact factor: 3.246

3.  Lycopodium clavatum exine microcapsules enable safe oral delivery of 3,4-diaminopyridine for treatment of botulinum neurotoxin A intoxication.

Authors:  T L Harris; C J Wenthur; A Diego-Taboada; G Mackenzie; T S Corbitt; K D Janda
Journal:  Chem Commun (Camb)       Date:  2016-03-18       Impact factor: 6.222

Review 4.  Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.

Authors:  Paulo José Salústio; Patrícia Pontes; Claúdia Conduto; Inês Sanches; Catarina Carvalho; João Arrais; Helena M Cabral Marques
Journal:  AAPS PharmSciTech       Date:  2011-09-27       Impact factor: 3.246

5.  Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery.

Authors:  Maryam Mansourpour; Reza Mahjub; Mohsen Amini; Seyed Naser Ostad; Elnaz Sadat Shamsa; Morteza Rafiee-Tehrani; Farid Abedin Dorkoosh
Journal:  AAPS PharmSciTech       Date:  2015-01-22       Impact factor: 3.246

Review 6.  Oral insulin delivery: how far are we?

Authors:  Pedro Fonte; Francisca Araújo; Salette Reis; Bruno Sarmento
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

7.  Inkjet printing of insulin microneedles for transdermal delivery.

Authors:  Steven Ross; Nicolaos Scoutaris; Dimitrios Lamprou; David Mallinson; Dennis Douroumis
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

8.  Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.

Authors:  Xiaoyang Li; Jianping Qi; Yunchang Xie; Xi Zhang; Shunwen Hu; Ying Xu; Yi Lu; Wei Wu
Journal:  Int J Nanomedicine       Date:  2012-12-28

Review 9.  Recent advances of chitosan nanoparticles as drug carriers.

Authors:  Jun Jie Wang; Zhao Wu Zeng; Ren Zhong Xiao; Tian Xie; Guang Lin Zhou; Xiao Ri Zhan; Shu Ling Wang
Journal:  Int J Nanomedicine       Date:  2011-04-11

Review 10.  Alginate Particles as Platform for Drug Delivery by the Oral Route: State-of-the-Art.

Authors:  Alejandro Sosnik
Journal:  ISRN Pharm       Date:  2014-04-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.